Skip to main content
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Articles
FDA Approvals
Anti–PD-1 Antibodies for NSCLC and Renal Carcinoma
Read More
Prostate Cancer
Upfront Docetaxel Markedly Improves Survival in Metastatic Prostate Cancer, at Reduced Cost
Read More
FDA Approvals
Enthusiasm Sky High for Immunotherapy with Anti–PD-1 Agents in Cancer
Read More
Generic Docetaxel Increases Risk of Neutropenia, Costs
Read More
Financial Distress Experienced by 40% of Patients with Cancer
Read More
Should Oncologists Consider Interests of Society at Large When Treating the Individual Patient?
Read More
Even When Adjusting for Improved Survival, Newer Cancer Drugs More Expensive Than Older Ones
Read More
ASCO Workgroup Proposes Consolidated Payments
Read More
Patients with Cancer Are Not Asking for Costly, Excessive Treatments
Read More
FDA Approvals
2014 Oncology Pipeline Looks Impressive
Read More
145
146
147
148
149
150
151
Page 148 of 244
Results 1471 - 1480 of 2439
